Skip to main content
OpenTrials

Clinical trial condition

Systemic Vasculitis

Explore clinical trials studying Systemic Vasculitis. Study availability and eligibility vary by location and protocol.

183 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Systemic Vasculitis trial results

Active, Not Recruiting

PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS

NCT04664465

Conditions
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, +34 more
Locations
  • CHU d'Angers Angers, France
  • CHRU de Brest Brest, France
  • CHD Vendée La Roche-sur-Yon, France
  • CH Le Mans Le Mans, France
View Trial Details
Active, Not Recruiting

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

NCT06046222

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • National Jewish Health Denver, Colorado, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • The Ohio State University Wexner Medical Center Columbus, Ohio, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.

NCT04157348

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • Research Site Denver, Colorado, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Albuquerque, New Mexico, United States
View all 50 locations
View Trial Details
Active, Not Recruiting

Explore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis

NCT06230354

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • Aberdeen Royal Infirmary - NHS Grampian Aberdeen, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Royal Infirmary of Edinburgh - NHS Lothian Edinburgh, United Kingdom
View Trial Details
Active, Not Recruiting

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

NCT03323476

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +22 more
Locations
  • Centre Hospitalier Universitaire Amiens Amiens, France
  • CHU Angers Angers, France
  • Centre Hospitalier Angoulême Angoulême, France
  • Centre Hospitalier ARRAS Arras, France
View all 57 locations
View Trial Details
Active, Not Recruiting

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

NCT06294236

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +33 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

NCT05030155

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • Service de Médecine Interne, Centre de référence " Maladies systémiques et autoimmunes rares, en particulier Vascularites nécrosantes et Sclérodermies systémiques "Hôpital Cochin Paris, France
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

NCT05732402

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
Locations
  • Investigational Site (523) Phoenix, Arizona, United States
  • Investigational Site (501) Phoenix, Arizona, United States
  • Investigational Site (524) Tucson, Arizona, United States
  • Investigational Site (506) Valencia, California, United States
View all 30 locations
View Trial Details

Related conditions